MYX 0.25% $3.94 mayne pharma group limited

What MYX chart shouts, page-225

  1. 227 Posts.
    lightbulb Created with Sketch. 142
    I know the feeling Raj, this time there's a lot at stake for management. For me the CEO has been very clear and consistent about what to expect for FY 24 and his credibility is on the line if it is not achieved.

    What I'll be looking for in these results primarily is cashflow, MYX needs to show that it is cashflow positive for continuing operations for the second half at least (there was a A$19M outflow from ongoing operations in the 1st half). That together with a total elimination of legacy costs from discontinued operations (they reported in the 1st half further obligations between A$10-20M left). So the upper end of total cash burn for the second half is $54M (A$34 for class action) less whatever positive cashflow from continued operations. I am hoping to see cash balance of about A$100M and a forecast of $50-100M additional cash flow in 2025.

    I will also be looking for growth from the 1st half in WH (as stated as late as June), I am resigned to a small growth for the second half but this area of growth is critical for the company.

    Given the multiple times that management has reiterated its forecast, I can't see how this is not going to go up tomorrow, we are trading at equivalent levels to the 2023FY report when we reported A$185M revenue and A$317M loss.
    GLTAH
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.